Q4 2020 Holdings
Filed 2021-02-19 | 52 holdings | $66.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $26.0M | 486,000 | 39.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $21.7M | 247,584 | 32.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $8.0M | 32,800 | 12.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.7M | 36,300 | 7.1% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $2.3M | 13,800 | 3.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.1M | 14,000 | 1.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $1.1M | 78,500 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $932.0K | 21,500 | 1.4% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $32.5K | 444,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $23.0K | 97,322 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $20.3K | 333,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $20.3K | 348,284 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $17.2K | 200,400 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $16.5K | 72,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $15.8K | 255,600 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $15.5K | 99,241 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $14.8K | 67,400 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $13.8K | 113,541 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $13.1K | 307,633 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $11.5K | 65,500 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $10.6K | 526,534 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $9.1K | 71,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $6.8K | 78,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $5.5K | 11,500 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $5.4K | 31,500 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $4.4K | 77,781 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.4K | 177,433 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $3.4K | 22,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.1K | 152,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.0K | 139,331 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $2.9K | 50,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.7K | 58,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.5K | 79,456 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.3K | 24,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $2.2K | 15,700 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $2.2K | 19,500 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.2K | 94,600 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.9K | 72,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.8K | 53,000 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 400047607 | $1.6K | 21,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.4K | 10,700 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.2K | 10,200 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.1K | 67,000 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $1.1K | 33,600 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $994 | 27,500 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $944 | 21,800 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $731 | 19,700 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $545 | 20,000 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $476 | 11,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $247 | 9,500 | 0.0% |